HealthQuill WHO
Israel’s Teva Pharmaceutical Industries Ltd’s, Weltruza, a once-monthly injection for treatment of schizophrenia in adults, has been approved by the US Food and Drug Administration.
Drugs Health Pharma

Israel’s Teva gets FDA nod for treating schizophrenia in adult patients

HQ Team October 10, 2026: Israel’s Teva Pharmaceutical Industries Ltd’s, Weltruza, a once-monthly injection for treatment of schizophrenia in adults, has been approved.

Read More
Non-communicable diseases (NCDs) accounted for eight of the world’s ten leading causes of death in 2023, up from 58% in 2000, according to a report by the World Health Organization.
Drugs Health Medical

Non-communicable diseases account for 74% of global deaths: WHO

HQ Team October 5, 2026:  Non-communicable diseases (NCDs) accounted for eight of the world’s ten leading causes of death in 2023, up from.

Read More
A measles outbreak in the South Asian nation of Bangladesh, which has killed nearly 1,000 people, is a major reversal of previous progress toward the elimination of the disease, according to an editorial in the International Journal of Infectious Diseases.
Drugs Health Opinion

Bangladesh’s measles outbreak an ‘early warning signal’: IJID says

HQ Team September 11, 2026: A measles outbreak in the South Asian nation of Bangladesh, which has killed nearly 1,000 people, is a.

Read More
The International Coordinating Group on Vaccine Provision (ICG), a coalition of health groups including the World Health Organization, has released 70,000 doses of its experimental Ervebo vaccine to the Democratic Republic of the Congo to assess its effectiveness in combating the Bundibugyo Ebola virus disease.
Drugs Health Research

ICG ships vaccines to Congo to test feasibility in Bundibugyo Ebola

HQ Team August 21, 2026: The International Coordinating Group on Vaccine Provision (ICG), a coalition of health groups including the World Health Organization,.

Read More
An epidemic caused by the Bundibugyo virus will continue to spread in the central African country of Congo at an “unprecedented speed” until every transmission chain is found and broken, Dr Tedros Adhanom Ghebreyesus, the Director-General of the World Health Organization, said.
Drugs Health Pharma

World still ‘playing catch-up’ with Ebola virus epidemic in Congo: WHO chief

HQ Team August 19, 2026: An epidemic caused by the Bundibugyo virus will continue to spread in the central African country of Congo.

Read More
Extracellular vesicles, or lipid particles released by human cells that cannot replicate, may serve as hidden reservoirs of the Covid-19 virus to contribute to their persistence and recurrence of the infection, a study finds.
Drugs

1 in 6 people rate bad primary care as “fine”, reveals 18-country survey

HQ Team July 24, 2026: Nearly one in six people surveyed across 18 countries rated a textbook case of poor primary care, including.

Read More
The death toll in the Ebola outbreak in the Democratic Republic of Congo (DRC) and Uganda climbed to 130 as the WHO stated the situation as “deeply disturbing.”
Drugs Health Pharma

Ebola outbreak deaths at 130, WHO says situation ‘deeply concerning’

The death toll in the Ebola outbreak in the Democratic Republic of Congo (DRC) and Uganda climbed to 130 as the WHO stated.

Read More
Cholera cases fell 17% month-on-month to 16,198 in 16 countries across three regions of the World Health Organization in March, according to a statement from the global health agency on April 30.
Climate Health Pharma

Global cholera cases decline 17% in March: Global health agency 

Cholera cases fell 17% month-on-month to 16,198 in 16 countries across three regions of the World Health Organization in March, according to a.

Read More
Factors like the patient’s character, carer’s personality and attitude towards the patient, relationship between the carer and patient, time spent together, and the severity of the illness impact the intensity of the caregiver burden.
Health Research

Work pressure is killing 840,000 people a year, finds UN report

The hard hat for physical labour saved millions of lives. So did the safety guard on the factory press, the chemical hazard label,.

Read More
Novartis AG’s treatment for malaria in infants and newborns weighing between two and five kilograms has been approved in Switzerland, and eight African nations are set to follow.
Drugs Health

WHO clears malaria treatment designed for newborns and infants

Swati Sri April 25, 2026: The World Health Organisation (WHO), prequalified the first anti malaria treatment developed specifically for newborns and young infants.

Read More